Conley Chee

Conley Chee is a seasoned professional with a rich background in the pharmaceutical and healthcare industries.

He is a distinguished alumnus of Ivey Business School at Western University, where he honed his business acumen.

At Novartis Oncology, Conley Chee held several key positions, including Global Head of Portfolio Management, Early Commercial Strategy, and Diagnostics, showcasing his leadership and strategic capabilities.

Prior to his global role, he served as the Vice President of Global Disease Lead for Lung at Novartis Oncology, illustrating his expertise in disease management.

Conley Chee also played crucial roles within the US market, such as Executive Business Director for US Oncology East and Senior Marketing Director for the Pituitary Franchise, exhibiting his marketing prowess.

His journey at Novartis includes being the Zometa Product Leader, the Oncology Institutional Marketing Director, and part of the Afinitor Marketing team, highlighting his versatility and adaptability.

Before his tenure at Novartis, Conley Chee was a pivotal figure at Pfizer Pharmaceuticals, where he led international business development efforts as the Senior Director and Team Leader, underscoring his global business acumen.

Additionally, his experience as an Executive Director in BD&L Negotiations at Novartis signifies his proficiency in negotiation and deal-making.

Conley Chee's diverse background also includes roles at Price Waterhouse Management Consultants as a Senior Consultant and as a Clinical Pharmacist at St. Pauls Hospital-University of British Columbia, showcasing his multifaceted skill set.

With a wealth of experience spanning various sectors within the healthcare and pharmaceutical domains, Conley Chee stands out as a seasoned professional with a track record of success and innovation.